Coronary Artery Disease is when the arteries of the heart become hardened and narrowed. The coronary arteries are the blood vessels in the heart that supply the rest of the body with oxygenated blood. Coronary Artery Disease is caused by cholesterol or plaque buildup in the inner walls of blood vessels of the heart. The symptoms of Coronary Artery Disease include chest pain, shortness of breath, and fatigue. As the leading cause of death in the United States, Coronary Artery Disease is treated with blood pressure lowering medications and sometimes corrected with surgery. Coronary Artery Disease can lead to a heart attack which can have lasting effects on the body, but changes in diet and smoking habits can increase the outlook of the Coronary Artery Disease patient.
Coronary Artery Disease Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Coronary Artery Disease below!
For more information on how to use Laverne, please read the How to Guide.
We have 2724 products for the study of Coronary Artery Disease that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence from our catalog of antibodies and ELISA kits.
Coronary Artery Disease is also known as Disease, Coronary Artery, Diseases, Coronary Artery, Disorder Of Coronary Artery, Heart: Coronary Artery, Artery Disease, Coronary.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.